Celltrion’s patch-type product to treat symptoms of Alzheimer’s was approved for use in Korea, the company said Friday.
Humedix signed an agreement with Daejeon’s G2GBIO to cooperate on the development of long-acting injectable drugs, the Kosdaq-listed biopharmaceutical company said Tuesday.
An 80-year-old man committed suicide after apparently killing his 78-year-old wife, who was suffering from Alzheimer's, according to the police on Wednesday.
Korea JoongAng Daily Sitemap
